Warning: This security is no longer trading.
Astellas completes acquisition of Audentes Therapeutics
Audentes Therapeutics, Inc. (BOLD): Price and Financial Metrics
BOLD Price/Volume Stats
| Current price | $2.71 | 52-week high | $15.24 |
| Prev. close | $2.69 | 52-week low | $2.63 |
| Day low | $2.69 | Volume | 50,200 |
| Day high | $2.77 | Avg. volume | 99,629 |
| 50-day MA | $3.23 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 60.43M |
BOLD Stock Price Chart Interactive Chart >
Audentes Therapeutics, Inc. (BOLD) Company Bio
Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company was founded in 2012 and is based in San Francisco, California.
BOLD Price Returns
| 1-mo | -10.56% |
| 3-mo | -27.54% |
| 6-mo | -76.04% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...